Is the ketogenic diet effective for managing type 2 diabetes?

Why this question matters

A ketogenic diet may help some adults with type 2 diabetes improve blood glucose and reduce medication needs in the short to medium term, especially when it leads to weight loss and is medically supervised. The overall assessment is mixed because long-term adherence, safety, cardiovascular effects, and comparisons with other sustainable dietary patterns remain important uncertainties.

The claim being judged

The claim asks whether the ketogenic diet is effective for managing type 2 diabetes. A ketogenic diet is usually very low in carbohydrate, moderate in protein, and higher in fat, with the goal of shifting the body toward using ketones as an energy source.

For type 2 diabetes, the most relevant outcomes are blood glucose control, hemoglobin A1c, body weight, insulin resistance, medication needs, cardiovascular risk factors, quality of life, and long-term complications. A diet can look favorable on one measure, such as short-term A1c reduction, while raising questions on another, such as LDL cholesterol or long-term adherence.

This claim also depends on what is meant by “effective.” For some people, ketogenic eating may be a useful tool when paired with monitoring and medication adjustment. For others, a less restrictive low-carbohydrate, Mediterranean, high-fiber, calorie-reduced, or individualized eating pattern may be more practical and similarly useful.

What the evidence shows

Clinical studies and reviews generally suggest that carbohydrate restriction, including ketogenic or very-low-carbohydrate diets, can reduce blood glucose and A1c in some adults with type 2 diabetes, particularly over the first several months. Some participants also reduce or discontinue diabetes medications, but this should be done only with clinician supervision because medication doses may need rapid adjustment.

Weight loss appears to be an important part of the observed benefit. When people lose weight, insulin sensitivity and glycemic control often improve, regardless of the specific diet pattern. This makes it challenging to separate the effect of ketosis itself from the effects of lower calorie intake, reduced carbohydrate intake, and weight reduction.

Comparisons with other diets are not uniform. Some trials find larger short-term improvements with very-low-carbohydrate diets, while others show comparable results once weight loss, adherence, and support are taken into account. Guidelines generally allow low-carbohydrate eating as one possible option rather than as the single preferred approach for all people with type 2 diabetes.

Safety considerations matter. Ketogenic diets can increase the risk of hypoglycemia if used with insulin or sulfonylureas unless medications are adjusted. They may also affect LDL cholesterol, constipation, nutrient intake, kidney stone risk in susceptible people, and social or psychological burden related to dietary restriction.

Where uncertainty remains

The strongest uncertainty is durability. Many people find very-low-carbohydrate diets difficult to maintain for years, and benefits may shrink if carbohydrate intake rises or weight is regained. Longer trials with real-world adherence data are especially important for judging long-term management.

There is also uncertainty about which patients are most likely to benefit and which may face higher risk. People using glucose-lowering medications, people with kidney disease, pregnant people, people with a history of eating disorders, and people taking SGLT2 inhibitors may require special caution and individualized medical advice.

Another open question is whether ketogenic diets improve long-term diabetes outcomes beyond A1c, such as cardiovascular events, kidney outcomes, neuropathy, retinopathy, or mortality. Most available evidence focuses on intermediate markers rather than long-term clinical endpoints.

The three parts of the claim

The umbrella claim is actually several claims bundled into one. Each needs its own evaluation.

Common questions